Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial

Peer Review reports

Original Submission
20 Jan 2023	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
7 Apr 2023	Author responded	Author comments - Roland Seiler
Resubmission - Version 3
7 Apr 2023	Submitted	Manuscript version 3
11 Apr 2023	Author responded	Author comments - Roland Seiler
Resubmission - Version 4
11 Apr 2023	Submitted	Manuscript version 4
12 Apr 2023	Author responded	Author comments - Roland Seiler
Resubmission - Version 5
12 Apr 2023	Submitted	Manuscript version 5
25 Apr 2023	Author responded	Author comments - Roland Seiler
Resubmission - Version 6
25 Apr 2023	Submitted	Manuscript version 6
Publishing
27 Apr 2023	Editorially accepted
11 May 2023	Article published	10.1186/s12894-023-01262-1

Back to article page